Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
LLY compared with RARE: revenue, margins and what each company keeps, and the suppliers and customers both name
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
RARE
Ultragenyx Pharmaceutical Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
LLY
ELI Lilly & Co
vs
RARE
Ultragenyx Pharmaceutical Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Co-movers
Desk
News
Calendar
Saved
Search
Co-movers
daily closes
Method
›
Moved together
LLY
with
RARE
No shared trading history for LLY and RARE.
Shared co-movers: not yet measured (RARE).
LLY, solid
RARE, hatched
r = correlation
Bar = r to r 0.75
Source: daily closes
LLY
ELI Lilly & Co
Change
1,407.25
▼
−0.27%
· post 1,416.42
Mkt cap
$1.3T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
RARE
Ultragenyx Pharmaceutical Inc.
Change
16.63
▲
+2.01%
· post 15.90
Closed
Nov 3 '26
Mkt cap
$1.6B
Revenue
$214M
Q2 FY26
Revenue
$673M
FY25
vs
Compare
Closed
Nov 3 '26
LLY
ELI Lilly & Co
vs
RARE
Ultragenyx Pharmaceutical Inc.
1,407.25
▼
−0.27%
post 1,416.42
Price
16.63
▲
+2.01%
post 15.90
$1.3T
Mkt cap
$1.6B
Q3 FY26
$24.4B
Revenue
$214M
Q2 FY26
FY25
$65.2B
Revenue
$673M
FY25
Change
Change
LLY
1,407.25
▼
−0.27%
vs
RARE
16.63
▲
+2.01%
Closed
Nov 3 '26